DNA damage response signaling as a predictive biomarker and synergistic therapeutic target for anti-PD-1/PD-L1 immunotherapy in non-small cell lung cancer.

ABSTRACT:

SUBMITTER: Zhu Z 

PROVIDER: S-EPMC6068455 | biostudies-literature | 2018 Aug

REPOSITORIES: biostudies-literature